Emmaus Life Sciences has acquired 2 companies. A total of 1 acquisition came from private equity firms.
Emmaus Life Sciences has acquired in 2 different US states. The Company’s most targeted sectors include healthcare services (50%) and life science (50%).
21250 Hawthorne Boulevard Suite 800,
Torrance, California
90503
United States,
(949) 420-4400
www.emmausmedical.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2019-01-07 |
EMI · Life Science
Torrance, California EMI is a developer of treatments and therapies for rare and orphan diseases. The company's research on sickle cell disease was initiated by Yutaka Niihara, MD, MPH, Chairman and CEO of Emmaus, at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. EMI was founded in 2000 and is based in Torrance, California. |
- | Merger |
GPB Capital
PE
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
